FMP

FMP

Enter

SAVA - Cassava Sciences, In...

Financial Summary of Cassava Sciences, Inc.(SAVA), Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative

photo-url-https://financialmodelingprep.com/image-stock/SAVA.png

Cassava Sciences, Inc.

SAVA

NASDAQ

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

19.64 USD

-1.55 (-7.89%)

About

ceo

Mr. Remi Barbier

sector

Healthcare

industry

Biotechnology

website

https://www.cassavasciences.com

exchange

NASDAQ

Description

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

CIK

0001069530

ISIN

US14817C1071

CUSIP

14817C107

Address

7801 North Capital of Texas Hi...

Phone

512 501 2444

Country

US

Employee

29

IPO Date

Jul 14, 2000

Summary

CIK

0001069530

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

14817C107

ISIN

US14817C1071

Country

US

Price

19.64

Beta

-0.4

Volume Avg.

731.65k

Market Cap

848.94M

Shares

-

52-Week

12.32-32.1

DCF

2.89

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-8.47

P/B

-

Website

https://www.cassavasciences.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest SAVA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep